Collegium Pharmaceutical Financials

Values in thousands	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$193,520	$205,449	$209,361	$188,000
Gross Profit	117,246	128,378	129,171	108,384
EBITDA	87,901	303,566	121,709	94,096
EBIT	31,965	133,830	65,203	37,488
Net Income	14,496	16,963	31,507	11,983
Net Change In Cash	193,520	205,449	209,361	188,000
Free Cash Flow	56,843	122,359	78,250	72,374
Cash	268,648	251,102	169,946	117,348
Basic Shares	40,065	39,701	39,439	39,075

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$780,567	$631,449	$566,767	$463,933
Gross Profit	463,257	377,344	326,169	209,488
EBITDA	401,005	341,702	308,328	173,305
EBIT	174,931	172,542	159,072	34,366
Net Income	62,870	69,190	48,155	-25,002
Net Change In Cash	780,567	631,449	566,767	463,933
Cost of Revenue				-12,738
Free Cash Flow	327,583	203,328	274,288	122,608
Cash	251,102	70,565	238,947	173,688
Basic Shares	39,701	40,424	41,788	33,829